JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Commonest Cancers in Pakistan - Findings and Histopathological Perspective from a Premier Surgical Pathology Center in Pakistan
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Commonest Cancers in Pakistan - Findings and Histopathological Perspective from a Premier Surgical Pathology Center in Pakistan
Ahmad, Zubair; Idrees, Romana; Fatima, Saira; Uddin, Nasir; Ahmed, Arsalan; Minhas, Khurram; Memon, Aisha; Fatima, Syeda Samia; Arif, Muhammad; Hasan, Sheema; Ahmed, Rashida; Pervez, Shahid; Kayani, Naila;
  PDF(new window)
 Abstract
Context: There are no recent authoritative data about incidence and prevalence of various types of cancers in Pakistan. Aim: To determine the frequency of malignant tumors seen in our practice and provide a foundation for building a comprehensive cancer care strategy. Materials and Methods: 10,000 successive cases of solid malignant tumors reported in 2014 were included. All cases had formalin fixed, paraffin embedded specimens available and diagnosis was based on histological examination of H&E stained slides plus ancillary studies at the Section of Histopathology, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi. The latest WHO classifications were used along with the latest CAP protocols for reporting and the most updated TNM staging. Results: There were 9,492 (94.9%) primary tumors while 508 (5.1%) were metastatic. Some 5,153 (51.5%) were diagnosed in females and 4,847 (48.5%) in males. The commonest malignant tumors in females were breast (32%), esophagus (7%), lymphomas (6.8%), oral cavity (6.7%) and ovary (4.8%), while in males they were oral cavity (13.9%), lymphomas (12.8%), colorectum (7.9%), stomach (6.9%) and esophagus (6.6%). Malignant tumors were most common in the 5th, 6th and 7th decades. About 8% were seen under 20 years of age. Conclusions: Oral cavity and gastrointestinal cancers continue to be extremely common in both genders. Breast and esophageal cancers are prevalent in females. Lung and prostate cancer are less common than in the west. Ovarian cancer was very common but cervix cancer was less so.
 Keywords
Cancer;carcinoma;lymphoma;sarcoma;decade-wise age data;histological types;
 Language
English
 Cited by
 References
1.
Abdifard E, Ghaderi S, Hosseini S, et al (2013). Incidence trends of colorectal cancer in the West of Iran during 2000-2005. Asian Pac J Cancer Prev, 14, 1807-11. crossref(new window)

2.
Ahmad Z, Arshad H, Fatima S, et al (2013). Gastrointestinal, liver and biliary tract pathology: a histopathological and epidemiological perspective from Pakistan with a review of the literature. Asian Pac J Cancer Prev, 14, 6997-7005. crossref(new window)

3.
Zubair Ahmad, Huma Arshad, Sheema H. Hasan, et al (2011). CNS neoplasms in Pakistan, a pathological perspective. Asian Pac J Cancer Prev, 12, 317-21.

4.
AIRT Working Group (2006). Italian cancer figures-report 2006: 1. Incidence, mortality and estimates. Epidemiol Prev, 30, 8-10, 12-28, 30-101.

5.
AIRTUM Working group; CCM; AIEOP Working Group (2013). Italian cancer figures, report 2012: Cancer in children and adolescents. Epidemiol Prev, 37, 1-225.

6.
Bafandeh Y, Hashemzadeh S, Sokouti M, et al (2006). Clinicopathologic characteristics of esophageal cancer patients in northwest Iran--very low incidence of adenocarcinomas. Asian Pac J Cancer Prev, 7, 480-2.

7.
Bahr J, van den berg N, Kraywinkel K, et al (2015). Prognosis of population related morbidity for common cancers in Germany - Effects on health care. Dtsch Med Wochenschr, 140, 80-8.

8.
Bao PP, Li K, Wu CX, et al (2013). [Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002-2010]. Zhonghua Er Ke Za Zhi, 51, 288-94.

9.
Beral V, Evans S, Shaw H, et al (1983). Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol, 109, 165-72. crossref(new window)

10.
Berg JW, Hutter RV (1995). Breast cancer. Cancer, 75, 257-69. crossref(new window)

11.
Brawley OW (1997). Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer, 80, 1857-63. crossref(new window)

12.
Brennan P, Bogillot O, Cordier S, et al (2000). Cigarette smoking and bladder cancer in men: a pooled analysis of 11 casecontrol studies. Int J Cancer, 86, 289-94. crossref(new window)

13.
Casson P (1980). Basal cell carcinoma. Clin Plast Surg, 7, 301-11.

14.
Cannistra SA (2004). Cancer of the ovary. N Engl J Med, 351, 2519-29. crossref(new window)

15.
CBTRUS (2008), Statistical report: primary brain tumors in the united states, 2000-2004. published by the central brain tumor registry of the united states.

16.
Center MM, Jemal A, Smith RA, et al (2009). Worldwide variations in colorectal cancer. CA Cancer J Clin, 59, 366-78. crossref(new window)

17.
Cooter M, Soliman AS, Pavlou P, et al (2015). Incidence and time trends of cancer in Cyprus over 11 years (1998-2008). Tumori, 101, 8-15. crossref(new window)

18.
Cresanta JL (1992). Epidemiology of cancer in the United States. Prim Care, 19, 419-41.

19.
Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62. crossref(new window)

20.
Crowson AN (2006). Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol, 19, 5127-47.

21.
Curado MP, Edwards B, Shin HR, (eds) (2007). Cancer incidence in five contienents , IARC, Lyon, France.

22.
de Camargo B, de Oliveria Santos M, Rebelo MS, et al (2010). Cancer incidence among children and adolescents in Brazil. First report of 14 population-based cancer registries. Int J Cancer, 126, 715-20. crossref(new window)

23.
D’Souza ND, Murthy NS, Aras RY (2013). Projection of cancer incidence cases for India -till 2026. Asian Pac J Cancer Prev, 14, 4379-86. crossref(new window)

24.
Du Yx, Cha Q, Chen XW, et al (1996). An epidemiological study of risk factors for lung cancer in Guangzhou, China. Lung cancer, 14, 9-37. crossref(new window)

25.
Edge SB, Byrd DR, Compton CC et al (2010). AJCC Cancer Staging Manual ed. 7, New York, Springer.

26.
Epstein JI, Algaba F, Allsbrook Jr WC, et al (2004). Acinar Adenocarcinoma. In Eble JN, Santer G, Epstein JI, Sesterhenn IA eds: WHO classification of tumors. tumors of the urinary system and male genital organs. IARC press, Lyon, 162-92.

27.
Ferlay J, Bray F, Pisani P, et al (2001). Globocan 2000: Cancer incidence, mortality and prevalence worldwide. IARC press: Lyon.

28.
Haddadin WJ (2005). Malignant lymphoma in Jordan: a retrospective analysis of 347 cases according to the World Health Organization classification. Ann Saudi Med, 25, 398-403.

29.
Herszenyi L, Tulassay Z (2010). Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci, 14, 249-58.

30.
Jain S, Saxena S, Kumar A (2014). Epidemiology of prostate cancer in India. Meta Gene, 2, 596-605. crossref(new window)

31.
Jedy-Agba E, Curado MP, Ogunbiyi O, et al (2012). Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol, 36, 271-8. crossref(new window)

32.
Jemal A, Tiwari RC, Murray T, et al (2004). Cancer statistics, 2004. CA Cancer J Clin, 54, 8-29. crossref(new window)

33.
Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics, 2006. CA Cancer J Clin, 56, 106-30. crossref(new window)

34.
Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66. crossref(new window)

35.
Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. crossref(new window)

36.
Jemal A, Thun MJ, Ries LA, et al (2008). Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst, 100, 1672-94. crossref(new window)

37.
Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49. crossref(new window)

38.
Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. crossref(new window)

39.
Khan A, Farooqui A, Raza Y, et al (2013). Prevalence, diversity and disease association of Helicobacter Pylori in dyspeptic patients from Pakistan. J Infect Dev Ctries, 7, 220-8.

40.
Khuhaprema T, Srivatanakul P (2008). Colon and rectum cancer in Thailand: an overview. Jpn J Clin Oncol, 38, 237-43. crossref(new window)

41.
Li K, Husing A, Fortner RT, et al (2015). An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study. Br J Cancer, 112, 1257-65. crossref(new window)

42.
Lin Y, Totsuka Y, He Y, et al (2013). Epidemiology of esophageal cancer in Japan and China. J Epidemiol, 23, 233-42. crossref(new window)

43.
Miwa H, Go MF, Sato N (2002). H Pylori and gastric cancer: the Asian enigma. Am J Gastroenterol, 97, 1106-12. crossref(new window)

44.
Msyamboza KP, Dzamalala C, Mdokwe C, et al (2012). Burden of cancer in Malawi: common types, incidence and trends: national population-based cancer registry. BMC Res Notes, 5, 149. crossref(new window)

45.
Murthy NS, Chaudhry K, Rath GK (2008). Burden of cancer and projections for 2016, Indian scenario: gaps in the availability of radiotherapy treatment facilities. Asian Pac J Cancer Prev, 9, 671-7.

46.
Muscat JE, Wynder EL (1992). Tobacco, alcohol, asbestos and occupational risk factors forlaryngeal cancer. Cancer, 69, 2241-51.

47.
Nanda kumar A, Ramnath T, Chaturvedi M (2010). The magnitutde of cancer breast in India: a summary. India J Surg Oncol, 1, 8-9. crossref(new window)

48.
Negri E, La Vecchia C (2001). Epidemiology and prevention of bladder cancer. Eur J Cancer Prev, 10, 7-14. crossref(new window)

49.
Papathoma P, Thomopoulos TP, Karalexi MA, et al (2015). Childhood central nervous system tumours: Incidence and time trends in 13 Southern and Eastern European cancer registries. Eur J Cancer, 51, 1444-55. crossref(new window)

50.
Parkin DM, Pisani P, Ferlay J (1994). Estimate of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 59, 494-504. crossref(new window)

51.
Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43. crossref(new window)

52.
Parkin DM, Bray F, Ferlay J, et al (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6. crossref(new window)

53.
Parkin DM, Whelan SL, Ferlay J, et al (2003), Thomas DB. Cancer incidence in five continents. IARC Scientific Publication No. 155. IARC press: Lyon.

54.
Pisani P, Bray F, Parkin DM (2002). Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer, 97, 72-81. crossref(new window)

55.
Radziszewska A, Karczmarek-Borowska B, Gradalska-Lampart M, et al (2015). [Epidemiology, prevention and risk morbidity factors for lung cancer]. Pol Merkur Lekarski, 38, 113-8.

56.
Rafferty MA, Fenton JE, Jones AS (2001). The history, aetiology and epidemiology of laryngeal carcinoma. Clin Otolaryngol Allied Sci, 26, 442-6. crossref(new window)

57.
Roman E, Smith AG (2011). Epidemiology of lymphomas. Histopathol, 58, 4-14. crossref(new window)

58.
Sankaranarayanm R, Masuyer E, Swaminathan R, et al (1998). Head and neck cancer : a global perspective on epidemiology and prognosis. Anti cancer Res, 18, 4779-86.

59.
Sharma P, Saxena S, Aggarwal P (2010). Trends in the epidemiology of oral squamous cell carcinoma in Western UP: an institutional study. Indian J Dent Res, 21, 316-9. crossref(new window)

60.
Shin HR, Masuyer E, Ferlay J, et al (2010). Cancer in Asia - Incidence rates based on data in cancer incidence in five continents IX (1998-2002). Asian Pac J Cancer Prev, 11, 11-6.

61.
Silverman SJR (2001). Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenges. J Am Dent Assoc, 132, 75-115. crossref(new window)

62.
Smith A, Howell D, Patmore R, et al (2011). Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer, 105, 1684-92. crossref(new window)

63.
Smith A, Crouch S, Lax S, et al (2015). Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's haematological malignancy research network. Br J Cancer, 112, 1575-84. crossref(new window)

64.
Sriplung H, Sontipong S, Martin N, et al (2005). Cancer incidence in Thailand, 1995-1997. Asian Pac J Cancer Prev, 6, 276-81.

65.
Sriplung H, Wiangnon S, Sontipong S, et al (2006). Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev, 7, 239-44.

66.
Takiar R, Srivastav A (2008). Time trends in breast and cervix cancer of women in India - (1990-2003). Asian Pac J Cancer Prev, 9, 777-80.

67.
Washington K ed (2013). Reporting on Cancer Specimens. Case Summaries and background documentation. College of American Pathologists (CAP). Illinois, CAP press

68.
Weir HK, Thun MJ, Hankey BF, et al (2003). Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst, 95, 1276-99. crossref(new window)

69.
Williams MD, Sandler AB (2001). The epidemiology of lung cancer. Cancer Treat Res, 105, 31-52. crossref(new window)

70.
Xie WC, Chan MH, Mak KC, et al (2012). Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008. Asian Pac J Cancer Prev, 13, 3911-6. crossref(new window)

71.
Yeole BB (2007). Trends in incidence of head and neck cancers in India. Asian Pac J Cancer Prev, 8, 607-12.

72.
Zini A, Czerninski R, Vered Y, et al (2009). Trends of oral and pharyngeal cancer in Israel, by gender, age, ethnic group, and country of origin: 1970-2006. Community Dent Oral Epidemiol, 37, 547-54. crossref(new window)

73.
Zini A, Czerninski R, Sgan-Cohen HD (2010). Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med, 39, 299-305.

74.
Zini A, Nasser N, Vered Y (2012). Oral and pharyngeal cancer among the Arab population in Israel from 1970 to 2006. Asian Pac J Cancer Prev, 13, 585-9. crossref(new window)